Skip to main content

Table 3 Primary outcomes related to diabetes, hypertension and dyslipidemia GPCs, expressed as weighted mean differences between intervention and control groups

From: Results from the CLUES study: a cluster randomized trial for the evaluation of cardiovascular guideline implementation in primary care in Spain

  WMD 95% CI p ICC
Annual HbA1c testing (diabetes) 3.83 3.49 to 11.15 0.297 0.0309
Annual general laboratory testing (hypertension) 16.22 −7.35 to 39.80 0.172 0.0039
Eligible women with CR assessment (dyslipidemia) 13.58 5.00 to 22.16 0.003 0.0223
Eligible men with CR assessment (dyslipidemia) 12.91 5.24 to 20.57 0.001 0.0000
  1. p-value derived by Student’s t-test
  2. CR cardiovascular risk, CI Confidence Interval, ICC intracluster correlation coefficient, WMD weighted mean difference